Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wolters Website

Pamela L. Wolters, Ph.D.

Selected Publications

1)  Weiss B, Widemann BC, Wolters P, Dombi E, Vinks AA, Cantor A, Korf B, Perentesis J, Gutmann DH, Schorry E, Packer R, Fisher MJ.
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study.
Pediatr Blood Cancer. 61: 982-6, 2014.
[Journal]
2)  Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A.
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.
Neurology. 81: S6-14, 2013.
[Journal]
3)  Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B.
Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.
J Pediatr Psychol. 37: 713-24, 2012.
[Journal]
4)  Steffen-Smith EA, Wolters PL, Albert PS, Baker EH, Shimoda KC, Barnett AS, Warren KE.
Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.
Childs Nerv Syst. 24: 807-13, 2008.
[Journal]
5)  Nathan PC, Whitcomb T, Wolters PL, Steinberg SM, Balis FM, Brouwers P, Hunsberger S, Feusner J, Sather H, Miser J, Odom LF, Poplack D, Reaman G, Bleyer WA.
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P.
Leuk. Lymphoma. 47: 2488-504, 2006.
[Journal]
6)  Martin S, Wolters PL, Baldwin A, Roderick MC, Toledo-Tamula MA, Gillespie A, Widemann B.
Attitudes About Internet Support Groups Among Adolescents and Young Adults with Neurofibromatosis Type 1 and their Parents.
J Genet Couns. [Epub ahead of print], 2014.
[Journal]
7)  Widemann BC, Dombi E, Gillespie A, Wolters PL, Belasco J, Goldman S, Korf BR, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran MW, Perentesis JP, Reddy A, Wright JJ, Kim A, Steinberg SM, Balis FM.
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Neuro-oncology. 16: 707-18, 2014.
[Journal]
8)  Plotkin SR, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Widemann BC.
Achieving consensus for clinical trials: the REiNS International Collaboration.
Neurology. 81: S1-5, 2013.
[Journal]
9)  Widemann BC, Blakeley JO, Dombi E, Fisher MJ, Hanemann CO, Walsh KS, Wolters PL, Plotkin SR.
Conclusions and future directions for the REiNS International Collaboration.
Neurology. 81: S41-4, 2013.
[Journal]
10)  Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R, Shih J, Camphausen K.
A phase 2 study of pegylated interferon a-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
Cancer. 118: 3607-13, 2012.
[Journal]
11)  Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV.
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
AIDS Care. 24: 1092-6, 2012.
[Journal]
12)  Martin S, Calabrese SK, Wolters PL, Walker KA, Warren K, Hazra R.
Family functioning and coping styles in families of children with cancer and HIV disease.
Clin Pediatr. 51: 58-64, 2012.
[Journal]
13)  Martin S, Gillespie A, Wolters PL, Widemann BC.
Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.
Contemp Clin Trials. 32: 10-5, 2011.
[Journal]
14)  Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
AIDS Patient Care STDS. 23: 593-601, 2009.
[Journal]
15)  Wolters PL, Gropman AL, Martin SC, Smith MR, Hildenbrand HL, Brewer CC, Smith AC.
Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.
Pediatr. Neurol. 41: 250-8, 2009.
[Journal]
16)  Elliott-DeSorbo DK, Martin S, Wolters PL.
Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.
J. Acquir. Immune Defic. Syndr. 52: 364-70, 2009.
[Journal]
17)  Baschnagel A, Wolters PL, Camphausen K.
Neuropsychological testing and biomarkers in the management of brain metastases.
Radiat Oncol. 3: 26, 2008.
[Journal]
18)  Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, O'Neill BP, Fox E, MacDonald T, Beck H, Packer RJ.
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas.
Pediatr. Neurol. 36: 293-300, 2007.
[Journal]
19)  Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, Roby G, Elliott-DeSorbo DK.
The Antiretroviral Regimen Complexity Index. A novel method of quantifying regimen complexity.
J. Acquir. Immune Defic. Syndr. 45: 535-44, 2007.
[Journal]
20)  Martin SC, Wolters PL, Smith AC.
Adaptive and maladaptive behavior in children with Smith-Magenis Syndrome.
J Autism Dev Disord. 36: 541-52, 2006.
[Journal]
21)  Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.
Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).
Dev Neuropsychol. 30: 633-57, 2006.
[Journal]
22)  Tamula MA, Wolters PL, Walsek C, Zeichner S, Civitello L.
Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease.
Pediatrics. 112: 679-84, 2003.
[Journal]
23)  Wolters PL, Brouwers P, Civitello L, Moss HA.
Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study.
AIDS. 11: 1135-44, 1997.
[Journal]
24)  Wolters PL, Brouwers P, Moss HA, Pizzo PA.
Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities.
Pediatrics. 95: 112-9, 1995.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 7/14/2014.